Table 1 Cases of perinephric myxoid pseudotumor of fat reported in the literature
Author | Year | No. of Cases | Underlying Disease | Native Kidney vs. Transplant Kidney |
|---|---|---|---|---|
Tanas, et al. [4] | 2009 | 12 | Renal cell carcinoma | Native kidney (12/12) |
Dashti, et al. [1] | 2019 | 11 | Non-neoplastic chronic kidney disease | Native kidney (11/11) |
Thoeni, et al. [6] | 2021 | 1 | Non-neoplastic chronic kidney disease, transplant failure | Transplant kidney (1/1) |
Chen, et al. [10] | 2021 | 1 | Non-neoplastic chronic kidney disease | Native kidney (1/1) |
Pham, et al. [7] | 2022 | 2 | Non-neoplastic chronic kidney disease, transplant failure | Transplant kidney (2/2) |
Collins, et al. [34] | 2022 | 1 | Non-neoplastic chronic kidney disease | Native kidney (1/1) |
Hogan, et al. [2] | 2023 | 33 | Malignancy (27/33 cases, 82%) Non-neoplastic chronic kidney disease (6/33 cases, 18%) | Native kidney (33/33) |
Lee, et al. [8] | 2023 | 4 | Non-neoplastic chronic kidney disease (3/4 cases, 75%) No associated kidney disease reported (1/4 case, 25%) | Native kidney (4/4) |
Liu, et al. [3] | 2023 | 1 | Horseshoe kidney with obstructing renal calculus | Native kidney (1/1) |
Amato, et al. [35] | 2023 | 1 | Ureteropelvic junction obstruction | Native kidney (1/1) |
Ortiz-Rey, et al. [36] | 2023 | 1 | Urothelial carcinoma in situ of ureter | Native kidney / ureter (1/1) |
Broski, et al. [11] | 2024 | 17 | Non-neoplastic chronic kidney disease (11/17 cases, 65%) No associated kidney disease reported (6/17 cases, 35%) | Native kidney (13/17) Transplant kidney (4/17) |
Kallen, et al. [37] | 2024 | 1 | Polycystic kidney disease | Native kidney (1/1) |
Wu, et al. [38] | 2024 | 13 | End-stage renal disease and renal cysts (9/13 cases, 70%) Renal neoplasm (2/13 cases, 15%) Myeloma (1/13 cases, 7.5%) Lymphoma (1/13 cases, 7.5%) | Native kidney (13/13) |
Total No. of Cases | 99 | Native kidney (92/99) Transplant kidney (7/99) | ||